Adhering to the concept of "health makes the future", with modern biotechnology and pharmaceutical preparation technology as the innovation platform, Haiwang intelon develops cytokine protein therapeutic drugs and preventive biological products, creates the core competitiveness represented by independent intellectual property product research and development and professional marketing ability, and gradually establishes the leading position in the domestic market, At the same time, carry out international strategy.
Huge market potential leads to unlimited business opportunities
In the past, China's investment level in medical expenditure or disease prevention was far lower than that of developed countries. However, the vigorous economic development has improved people's lives, so the emphasis on health is also higher than before. In addition, the aging population has also led to a sharp increase in domestic demand for drugs. In addition, China's biotechnology is close to the international technology level, has a good development momentum, and the prospect is very optimistic. The company believes that China's biopharmaceutical industry will become more mature and bring unlimited business opportunities to the company.
Grasp the trend of science and technology, excellent R & D capability
Haiwang intelon has strong scientific research strength, and the R & D team has professional knowledge and rich R & D experience. The company has independent R & D capability, the pilot plant has reached GMP standard, and each laboratory is equipped with advanced research facilities and test instruments. The company also cooperates with a number of powerful professional biotechnology companies or research institutions, and has achieved good results. The biotechnology drugs developed and produced by the company have the advantages of low cost, high efficiency, safety and reliability, and have great development potential. In addition, for the core technology of new products, the company has obtained one invention patent for core technology, and is now applying for invention patents for a number of technologies. In the next three years, the company will launch several new products with independent intellectual property rights, with broad market prospects.
Enjoy brand advantage without fear of market competition
Haiwang's products use Haiwang pharmaceutical's licensed trademark "Haiwang", which is a well-known trademark in China. The brand has established outstanding reputation and popularity in China for many years. Brand advantage helps to improve the market's acceptance of various new drugs launched by the company in the future, and greatly improve the company's competitiveness.
Excellent enterprise professionals, strict quality control
The management of the company has professional background, rich enterprise experience, in-depth understanding of the development of the industry, looking forward to the future direction and strategy of the company, but also pay attention to staff training, and actively recruit professionals in the industry. The company is well aware that the quality of products and scientific research are equally important, and strictly control the quality, so the products have a good reputation in China. The company's current production are in accordance with GMP standards and operating guidelines, strict implementation of product monitoring.
Looking forward to the future and achieving the future
With strong R & D ability, professional marketing methods, strict quality control and excellent enterprise management, Haiwang intylon has accumulated rich management experience in China, and established a certain popularity, and successfully strive for considerable market coverage. The company will continue to move forward, expand production scale and improve R & D capacity, combine advanced technology, increase product types, and actively expand business to overseas market, and achieve human health in the future.